 | • レポートコード：GIR-23F3811 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Gemtuzumab Ozogamicin Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のゲムツズマブオゾガマイシン医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ゲムツズマブオゾガマイシン医薬品市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・5mg/バイアル、4.5mg/バイアル アプリケーション別セグメントは次のように区分されます。 ・病院、薬局 世界のゲムツズマブオゾガマイシン医薬品市場の主要なマーケットプレーヤーは以下のとおりです。 ・Pfizer 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - ゲムツズマブオゾガマイシン医薬品の概要 - タイプ別分析（2017年vs2021年vs2028年）：5mg/バイアル、4.5mg/バイアル - アプリケーション別分析（2017年vs2021年vs2028年）：病院、薬局 - 世界のゲムツズマブオゾガマイシン医薬品市場規模・予測 - 世界のゲムツズマブオゾガマイシン医薬品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：5mg/バイアル、4.5mg/バイアル ・アプリケーション別分析2017年-2028年：病院、薬局 ・ゲムツズマブオゾガマイシン医薬品の北米市場分析 - ゲムツズマブオゾガマイシン医薬品の北米市場：タイプ別市場規模2017年-2028年 - ゲムツズマブオゾガマイシン医薬品の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ゲムツズマブオゾガマイシン医薬品のヨーロッパ市場分析 - ：ゲムツズマブオゾガマイシン医薬品のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ゲムツズマブオゾガマイシン医薬品のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ゲムツズマブオゾガマイシン医薬品のアジア太平洋市場分析 - ゲムツズマブオゾガマイシン医薬品のアジア太平洋市場：タイプ別市場規模2017年-2028年 - ゲムツズマブオゾガマイシン医薬品のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ゲムツズマブオゾガマイシン医薬品の南米市場分析 - ゲムツズマブオゾガマイシン医薬品の南米市場：タイプ別市場規模2017年-2028年 - ゲムツズマブオゾガマイシン医薬品の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ゲムツズマブオゾガマイシン医薬品の中東・アフリカ市場分析 - ゲムツズマブオゾガマイシン医薬品の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ゲムツズマブオゾガマイシン医薬品の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gemtuzumab Ozogamicin Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Gemtuzumab Ozogamicin Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Gemtuzumab Ozogamicin Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5mg/Vial segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gemtuzumab Ozogamicin Drugs include Pfizer, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gemtuzumab Ozogamicin Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5mg/Vial
4.5mg/Vial
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Gemtuzumab Ozogamicin Drugs market are listed below:
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gemtuzumab Ozogamicin Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gemtuzumab Ozogamicin Drugs, with price, sales, revenue and global market share of Gemtuzumab Ozogamicin Drugs from 2019 to 2022.
Chapter 3, the Gemtuzumab Ozogamicin Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gemtuzumab Ozogamicin Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gemtuzumab Ozogamicin Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gemtuzumab Ozogamicin Drugs.
Chapter 13, 14, and 15, to describe Gemtuzumab Ozogamicin Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Gemtuzumab Ozogamicin Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gemtuzumab Ozogamicin Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5mg/Vial
1.2.3 4.5mg/Vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Gemtuzumab Ozogamicin Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Gemtuzumab Ozogamicin Drugs Market Size & Forecast
1.4.1 Global Gemtuzumab Ozogamicin Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gemtuzumab Ozogamicin Drugs Sales in Volume (2017-2028)
1.4.3 Global Gemtuzumab Ozogamicin Drugs Price (2017-2028)
1.5 Global Gemtuzumab Ozogamicin Drugs Production Capacity Analysis
1.5.1 Global Gemtuzumab Ozogamicin Drugs Total Production Capacity (2017-2028)
1.5.2 Global Gemtuzumab Ozogamicin Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gemtuzumab Ozogamicin Drugs Market Drivers
1.6.2 Gemtuzumab Ozogamicin Drugs Market Restraints
1.6.3 Gemtuzumab Ozogamicin Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Gemtuzumab Ozogamicin Drugs Product and Services
2.1.4 Pfizer Gemtuzumab Ozogamicin Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gemtuzumab Ozogamicin Drugs Breakdown Data by Manufacturer
3.1 Global Gemtuzumab Ozogamicin Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gemtuzumab Ozogamicin Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Gemtuzumab Ozogamicin Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Gemtuzumab Ozogamicin Drugs Manufacturer Market Share in 2021
3.5 Global Gemtuzumab Ozogamicin Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gemtuzumab Ozogamicin Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gemtuzumab Ozogamicin Drugs Market Size by Region
4.1.1 Global Gemtuzumab Ozogamicin Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Region (2017-2028)
4.2 North America Gemtuzumab Ozogamicin Drugs Revenue (2017-2028)
4.3 Europe Gemtuzumab Ozogamicin Drugs Revenue (2017-2028)
4.4 Asia-Pacific Gemtuzumab Ozogamicin Drugs Revenue (2017-2028)
4.5 South America Gemtuzumab Ozogamicin Drugs Revenue (2017-2028)
4.6 Middle East and Africa Gemtuzumab Ozogamicin Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gemtuzumab Ozogamicin Drugs Sales in Volume by Type (2017-2028)
5.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Type (2017-2028)
5.3 Global Gemtuzumab Ozogamicin Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gemtuzumab Ozogamicin Drugs Sales in Volume by Application (2017-2028)
6.2 Global Gemtuzumab Ozogamicin Drugs Revenue by Application (2017-2028)
6.3 Global Gemtuzumab Ozogamicin Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2028)
7.2 North America Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2028)
7.3 North America Gemtuzumab Ozogamicin Drugs Market Size by Country
7.3.1 North America Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Gemtuzumab Ozogamicin Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2028)
8.2 Europe Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2028)
8.3 Europe Gemtuzumab Ozogamicin Drugs Market Size by Country
8.3.1 Europe Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Gemtuzumab Ozogamicin Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Gemtuzumab Ozogamicin Drugs Market Size by Region
9.3.1 Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gemtuzumab Ozogamicin Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2028)
10.2 South America Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2028)
10.3 South America Gemtuzumab Ozogamicin Drugs Market Size by Country
10.3.1 South America Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Gemtuzumab Ozogamicin Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Gemtuzumab Ozogamicin Drugs Market Size by Country
11.3.1 Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gemtuzumab Ozogamicin Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gemtuzumab Ozogamicin Drugs
12.3 Gemtuzumab Ozogamicin Drugs Production Process
12.4 Gemtuzumab Ozogamicin Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gemtuzumab Ozogamicin Drugs Typical Distributors
13.3 Gemtuzumab Ozogamicin Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Gemtuzumab Ozogamicin Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gemtuzumab Ozogamicin Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Gemtuzumab Ozogamicin Drugs Product and Services
Table 6. Pfizer Gemtuzumab Ozogamicin Drugs Sales (kUnits), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Gemtuzumab Ozogamicin Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (kUnits)
Table 8. Global Gemtuzumab Ozogamicin Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Gemtuzumab Ozogamicin Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Gemtuzumab Ozogamicin Drugs Production Capacity by Company, (kUnits): 2020 VS 2021
Table 11. Head Office and Gemtuzumab Ozogamicin Drugs Production Site of Key Manufacturer
Table 12. Gemtuzumab Ozogamicin Drugs New Entrant and Capacity Expansion Plans
Table 13. Gemtuzumab Ozogamicin Drugs Mergers & Acquisitions in the Past Five Years
Table 14. Global Gemtuzumab Ozogamicin Drugs Sales by Region (2017-2022) & (kUnits)
Table 15. Global Gemtuzumab Ozogamicin Drugs Sales by Region (2023-2028) & (kUnits)
Table 16. Global Gemtuzumab Ozogamicin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Gemtuzumab Ozogamicin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2022) & (kUnits)
Table 19. Global Gemtuzumab Ozogamicin Drugs Sales by Type (2023-2028) & (kUnits)
Table 20. Global Gemtuzumab Ozogamicin Drugs Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Gemtuzumab Ozogamicin Drugs Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Gemtuzumab Ozogamicin Drugs Price by Type (2017-2022) & (USD/Unit)
Table 23. Global Gemtuzumab Ozogamicin Drugs Price by Type (2023-2028) & (USD/Unit)
Table 24. Global Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2022) & (kUnits)
Table 25. Global Gemtuzumab Ozogamicin Drugs Sales by Application (2023-2028) & (kUnits)
Table 26. Global Gemtuzumab Ozogamicin Drugs Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Gemtuzumab Ozogamicin Drugs Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Gemtuzumab Ozogamicin Drugs Price by Application (2017-2022) & (USD/Unit)
Table 29. Global Gemtuzumab Ozogamicin Drugs Price by Application (2023-2028) & (USD/Unit)
Table 30. North America Gemtuzumab Ozogamicin Drugs Sales by Country (2017-2022) & (kUnits)
Table 31. North America Gemtuzumab Ozogamicin Drugs Sales by Country (2023-2028) & (kUnits)
Table 32. North America Gemtuzumab Ozogamicin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Gemtuzumab Ozogamicin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2022) & (kUnits)
Table 35. North America Gemtuzumab Ozogamicin Drugs Sales by Type (2023-2028) & (kUnits)
Table 36. North America Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2022) & (kUnits)
Table 37. North America Gemtuzumab Ozogamicin Drugs Sales by Application (2023-2028) & (kUnits)
Table 38. Europe Gemtuzumab Ozogamicin Drugs Sales by Country (2017-2022) & (kUnits)
Table 39. Europe Gemtuzumab Ozogamicin Drugs Sales by Country (2023-2028) & (kUnits)
Table 40. Europe Gemtuzumab Ozogamicin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Gemtuzumab Ozogamicin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2022) & (kUnits)
Table 43. Europe Gemtuzumab Ozogamicin Drugs Sales by Type (2023-2028) & (kUnits)
Table 44. Europe Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2022) & (kUnits)
Table 45. Europe Gemtuzumab Ozogamicin Drugs Sales by Application (2023-2028) & (kUnits)
Table 46. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Region (2017-2022) & (kUnits)
Table 47. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Region (2023-2028) & (kUnits)
Table 48. Asia-Pacific Gemtuzumab Ozogamicin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Gemtuzumab Ozogamicin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2022) & (kUnits)
Table 51. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Type (2023-2028) & (kUnits)
Table 52. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2022) & (kUnits)
Table 53. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales by Application (2023-2028) & (kUnits)
Table 54. South America Gemtuzumab Ozogamicin Drugs Sales by Country (2017-2022) & (kUnits)
Table 55. South America Gemtuzumab Ozogamicin Drugs Sales by Country (2023-2028) & (kUnits)
Table 56. South America Gemtuzumab Ozogamicin Drugs Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Gemtuzumab Ozogamicin Drugs Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2022) & (kUnits)
Table 59. South America Gemtuzumab Ozogamicin Drugs Sales by Type (2023-2028) & (kUnits)
Table 60. South America Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2022) & (kUnits)
Table 61. South America Gemtuzumab Ozogamicin Drugs Sales by Application (2023-2028) & (kUnits)
Table 62. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Region (2017-2022) & (kUnits)
Table 63. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Region (2023-2028) & (kUnits)
Table 64. Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Type (2017-2022) & (kUnits)
Table 67. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Type (2023-2028) & (kUnits)
Table 68. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Application (2017-2022) & (kUnits)
Table 69. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales by Application (2023-2028) & (kUnits)
Table 70. Gemtuzumab Ozogamicin Drugs Raw Material
Table 71. Key Manufacturers of Gemtuzumab Ozogamicin Drugs Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Gemtuzumab Ozogamicin Drugs Typical Distributors
Table 75. Gemtuzumab Ozogamicin Drugs Typical Customers
List of Figures
Figure 1. Gemtuzumab Ozogamicin Drugs Picture
Figure 2. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type in 2021
Figure 3. 5mg/Vial
Figure 4. 4.5mg/Vial
Figure 5. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Gemtuzumab Ozogamicin Drugs Revenue, (USD Million) & (kUnits): 2017 & 2021 & 2028
Figure 9. Global Gemtuzumab Ozogamicin Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Gemtuzumab Ozogamicin Drugs Sales (2017-2028) & (kUnits)
Figure 11. Global Gemtuzumab Ozogamicin Drugs Price (2017-2028) & (USD/Unit)
Figure 12. Global Gemtuzumab Ozogamicin Drugs Production Capacity (2017-2028) & (kUnits)
Figure 13. Global Gemtuzumab Ozogamicin Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Gemtuzumab Ozogamicin Drugs Market Drivers
Figure 15. Gemtuzumab Ozogamicin Drugs Market Restraints
Figure 16. Gemtuzumab Ozogamicin Drugs Market Trends
Figure 17. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. Gemtuzumab Ozogamicin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Gemtuzumab Ozogamicin Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Gemtuzumab Ozogamicin Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America Gemtuzumab Ozogamicin Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe Gemtuzumab Ozogamicin Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Gemtuzumab Ozogamicin Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America Gemtuzumab Ozogamicin Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Gemtuzumab Ozogamicin Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Gemtuzumab Ozogamicin Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global Gemtuzumab Ozogamicin Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Gemtuzumab Ozogamicin Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America Gemtuzumab Ozogamicin Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe Gemtuzumab Ozogamicin Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe Gemtuzumab Ozogamicin Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America Gemtuzumab Ozogamicin Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America Gemtuzumab Ozogamicin Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Gemtuzumab Ozogamicin Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Gemtuzumab Ozogamicin Drugs in 2021
Figure 76. Manufacturing Process Analysis of Gemtuzumab Ozogamicin Drugs
Figure 77. Gemtuzumab Ozogamicin Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
| 【ゲムツズマブオゾガマイシン医薬品について】 ゲムツズマブオゾガマイシン（Gemtuzumab Ozogamicin）は、特定のがん治療に用いられる抗体薬であり、その特異性と効能から、近年のがん治療において重要な役割を果たしています。この薬剤は、主に急性骨髄性白血病（AML）の治療に使われていますが、そのメカニズムや関連する技術についても理解することが重要です。 ゲムツズマブオゾガマイシンは、モノクローナル抗体の一種であり、特にCD33という抗原をターゲットにしています。CD33は、急性骨髄性白血病のような特定の血液癌細胞の表面に発現するタンパク質です。この抗体は、ゲムツズマブオゾガマイシンが結合した結果、競合的に目的の癌細胞に対して精密に攻撃を行います。また、この薬剤は抗体-薬物複合体（ADC）として分類されており、抗体が癌細胞に結合すると、内因的に抗がん剤であるオゾガマイシンを放出する仕組みになっています。この二重のメカニズムにより、ゲムツズマブオゾガマイシンはより効率的にがん細胞を標的化し、正常細胞へのダメージを最小限に抑えることができます。 ゲムツズマブオゾガマイシンの特徴として、まずその選択的な作用があります。これは、癌細胞に特異的に作用し、正常な細胞には傷害を与えにくいという利点を持っています。一般的な化学療法薬は、癌細胞だけでなく正常な細胞にも影響を及ぼすため、さまざまな副作用が懸念されますが、ゲムツズマブオゾガマイシンはそのようなリスクを軽減することが期待されています。 また、使用する際の投与方法も特徴的です。ゲムツズマブオゾガマイシンは静脈内投与され、その効果が現れるまでの時間も比較的早いとされています。服薬の方式や治療のスケジュールも、患者ごとに適切に調整できますので、個々の患者に最適な治療法を選択することが可能です。 さらに、ゲムツズマブオゾガマイシンは、単独での使用だけでなく、他の抗がん剤と併用されることが多く、治療の効果をさらに高めることが可能です。この併用療法によって、白血病を克服するための新たな戦略が進められています。特に、リツキシマブなどの異なる作用機序を持つ薬剤と組み合わせることで、相乗効果が期待できます。 用途としては、主に急性骨髄性白血病に使用されることが多いですが、今後はその他の血液がんに対する有効性を評価する研究が進められています。具体的には、急性前骨髄球性白血病（APL）や慢性骨髄性白血病（CML）などへの適応拡大が期待されています。 関連技術として、抗体医薬品の開発技術が挙げられます。この分野では、抗体の特異性を高めるための技術や、薬物輸送システムの革新が進められています。抗体に結合させる薬剤の選択やその化学的修飾も、効果的な治療を実現するための研究が続けられています。さらに、がん細胞の生物学的特性を理解することが、新たなターゲットの発見につながるため、基礎研究の重要性も高まっています。 副作用については、ゲムツズマブオゾガマイシンが正常な細胞には影響を与えにくいとはいえ、依然としていくつかの副作用が報告されています。例えば、感染症のリスクが増加する可能性や、肝機能の異常、アレルギー反応などです。したがって、治療を行う際には、患者の状態を綿密に観察する必要があります。 治療完了後のフォローアップも重要です。再発を防ぐための定期的な血液検査や、患者の生活習慣の見直しも重要な要素です。治療に伴う身体的なストレスだけでなく、精神的な面でもサポートを行うことが、患者の回復に寄与します。医療チームは、患者が安心して治療を受けられるように、周囲の理解やサポートを促す役割も担っています。 ゲムツズマブオゾガマイシンは、がん治療に新たな希望をもたらす薬剤であり、その研究や適応拡大は今後も続いていくでしょう。がんの治療は日々進化しており、その中でゲムツズマブオゾガマイシンが果たす役割は、ますます重要性を増しています。患者一人ひとりに対して適切な治療法を提供するために、研究者や医療従事者は絶えず新たな知見を追求し、最良の治療を追求し続けることが必要です。発展する医療技術とともに、がん患者に新たな希望と選択肢を提供することが、今後の研究と医療の最重要課題となるでしょう。 |